116 related articles for article (PubMed ID: 7724651)
1. The involvement of amyloid associated proteins in the formation of beta-protein filaments in Alzheimer's disease.
Potter H; Ma J; Das S; Kayyali U
Prog Clin Biol Res; 1994; 390():57-71. PubMed ID: 7724651
[No Abstract] [Full Text] [Related]
2. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.
Ma J; Yee A; Brewer HB; Das S; Potter H
Nature; 1994 Nov; 372(6501):92-4. PubMed ID: 7969426
[TBL] [Abstract][Full Text] [Related]
3. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease.
Potter H
Prog Brain Res; 1992; 94():447-58. PubMed ID: 1287729
[No Abstract] [Full Text] [Related]
4. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).
Mann DM; Iwatsubo T; Cairns NJ; Lantos PL; Nochlin D; Sumi SM; Bird TD; Poorkaj P; Hardy J; Hutton M; Prihar G; Crook R; Rossor MN; Haltia M
Ann Neurol; 1996 Aug; 40(2):149-56. PubMed ID: 8773595
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments.
Inestrosa NC; Alvarez A; Calderón F
Mol Psychiatry; 1996 Nov; 1(5):359-61. PubMed ID: 9154226
[No Abstract] [Full Text] [Related]
7. Neurobiology of Alzheimer's disease.
Peskind ER
J Clin Psychiatry; 1996; 57 Suppl 14():5-8. PubMed ID: 9024330
[TBL] [Abstract][Full Text] [Related]
8. [Alzheimer's disease and Down's syndrome. Some recent etiopathogenic data].
Golaz J; Charnay Y; Vallet P; Bouras C
Encephale; 1991; 17(1):29-31. PubMed ID: 1669030
[TBL] [Abstract][Full Text] [Related]
9. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.
Iwatsubo T; Saido TC; Mann DM; Lee VM; Trojanowski JQ
Am J Pathol; 1996 Dec; 149(6):1823-30. PubMed ID: 8952519
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation.
Nilsson LN; Arendash GW; Leighty RE; Costa DA; Low MA; Garcia MF; Cracciolo JR; Rojiani A; Wu X; Bales KR; Paul SM; Potter H
Neurobiol Aging; 2004 Oct; 25(9):1153-67. PubMed ID: 15312961
[TBL] [Abstract][Full Text] [Related]
11. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology.
Hyman BT
Ann Neurol; 1996 Aug; 40(2):135-6. PubMed ID: 8773592
[No Abstract] [Full Text] [Related]
13. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
Yilmazer-Hanke DM
Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis of Alzheimer's disease].
Alegre M; Noé E; Luquin MR
Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
[TBL] [Abstract][Full Text] [Related]
15. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
17. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
18. The proteins and genes of Alzheimer's disease.
Glenner GG
Biomed Pharmacother; 1988; 42(9):579-84. PubMed ID: 3071381
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of Alzheimer's disease.
Whitehouse PJ; Landreth G; Younkin S
Mol Genet Med; 1993; 3():95-137. PubMed ID: 8220165
[No Abstract] [Full Text] [Related]
20. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease.
Shimizu T; Fukuda H; Murayama S; Izumiyama N; Shirasawa T
J Neurosci Res; 2002 Nov; 70(3):451-61. PubMed ID: 12391606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
